PUMA BIOTECHNOLOGY, INC. (PBYI) [Rocket]

Date Filed	Type	Description
03/05/2021	GN	Polyphor Announces Financial Results for the Full-Year 2020
09/03/2020	GN	Knight Therapeutics Announces Filling of Supplement to a New Drug Submission for NERLYNX® (neratinib) to Treat HER2-Positive Metastatic Breast Cancer
09/03/2020	GN	Thérapeutique Knight annonce le dépôt d'un supplément à la présentation de drogue nouvelle pour NERLYNX® (nératinib) pour le traitement du cancer du sein HER2-positif métastatique
07/16/2019	GN	Knight Therapeutics Announces Health Canada Has Approved NERLYNX ® for Early-Stage Breast Cancer
07/16/2019	GN	Thérapeutique Knight annonce l'approbation par Santé Canada de NERLYNX® pour le traitement du cancer du sein au stade précoce
02/28/2019	GN	Predictive Technology Group Names Jay M. Moyes to Its Board of Directors
01/11/2019	GN	Knight Therapeutics Runs with Exclusive Canadian License to Puma's NERLYNX®
01/11/2019	GN	Thérapeutique Knight exploite une licence canadienne exclusive pour le produit NERLYNX® de Puma
08/23/2018	GN	Factors of Influence in 2018, Key Indicators and Opportunity within Patterson-UTI Energy, Puma Biotechnology, Echelon, McEwen Mining, New Gold, and Qudian Inc. Sponsored ADR — New Research Emphasizes Economic Growth
06/12/2018	GN	Detailed Research: Economic Perspectives on Amphenol, Hologic, Newell Brands, Ciena, SAExploration, and Puma Biotechnology — What Drives Growth in Today's Competitive Landscape
05/09/2018	BW	Puma Biotechnology Reports First Quarter 2018 Financial Results
04/25/2018	BW	Puma Biotechnology to Host Conference Call to Discuss First Quarter Financial Results
03/06/2018	BW	Puma Biotechnology to Present at Cowen's Annual Healthcare Conference